BTT-266 is an antagonist forcalcium channel, through suppression of the CaValpha1-AID-CaVbeta3 interaction, with a Ki of 1.4 µM. BTT-266 modulates the activation of voltage-dependent CaV2.2. BTT-266 exhibits analgesic efficacy against neuropathic pain in rats model[1].
Molecular Weight:
556.61
Purity:
98.90
CAS Number:
[2413939-89-4]
Formula:
C34H28N4O4
Target:
Calcium Channel
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted